Regulatory Insights

  1. Meeting The FDA's New Real-World Evidence Standards 5/27/2026

    FDA guidance is reshaping RWE strategy. Sponsors that build interoperable, audit-ready RWD infrastructure now will be best positioned for faster, defensible submissions.

  2. Where PRO Strategy Goes Wrong 5/27/2026

    PRO and COA strategy is now central to trial success. Organizations that capture meaningful patient experience data will gain stronger evidence and a regulatory advantage.

  3. Is The Industry Ready To Trust LLMs With Chart Review? 5/27/2026

    See how LLM-powered extraction transforms unstructured medical records into compliant, audit-ready clinical data with machine-scale speed, human oversight, and regulatory-grade accuracy.

  4. AI, Virtual Participants, and the Evolving FDA Regulatory Landscape 5/27/2026

    Understanding emerging requirements around transparency, risk, and governance is essential for responsibly advancing AI-driven innovation in regulated environments.

  5. Simultaneous Submissions And Managing Multiple Regulatory Pathways 5/27/2026

    Global regulators are increasingly aligned, creating new opportunities for sponsors to pursue near-simultaneous submissions across major markets

  6. A Practical Guide For Managing Multiple Global Regulatory Pathways 5/27/2026

    Global submissions are getting faster—and more complex. Explore a 7-step framework for aligning FDA and EMA pathways to reduce risk, duplication, and regulatory delays.

  7. De-Risking The Neurology IND: Lessons From Early FDA Engagement 5/27/2026

    Learn how early FDA alignment can help your neurology program move forward with greater clarity, confidence, and regulatory readiness.

  8. Successful EU MAA Submission Enabled By U.S.–EU Regulatory Collaboration 5/27/2026

    Facing EU MAA complexity? Learn how one oncology sponsor met a fixed EMA deadline through global regulatory coordination, rapid dossier adaptation, and real-time submission execution.

  9. Does Your CRO Excel In Oncology Regulatory Publishing? 5/27/2026

    Oncology approvals move fast. Learn how experienced CRO publishing teams help sponsors navigate RTOR, Project Orbis, and complex global submissions with confidence.

  10. Relieving Pressure During Preparation Of A High-Volume sNDA 5/27/2026

    Managing a complex sNDA under pressure? See how one sponsor achieved an early FDA submission through coordinated publishing, regulatory strategy, and flawless execution.